Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Oppenheimer Downgrades UiPath to Perform

Oppenheimer Downgrades UiPath to Perform

Oppenheimer analyst Brian Schwartz downgrades UiPath (NYSE:PATH) from Outperform to Perform.

November 3, 2022

1 minute read

Oppenheimer analyst Brian Schwartz downgrades UiPath (NYSE:PATH) from Outperform to Perform.

What’s Going On With C4 Therapeutics Stock?

December 15, 1:00 PM

C4 Therapeutics, Inc. (NASDAQ: CCCC) shares are trading higher Friday, and the stock has gained more than 350% over the past five days.

December 15, 6:40 AM

Citigroup analyst Michael Ward initiates coverage on Willis Towers Watson (NASDAQ:WTW) with a Neutral rating and announces Price Target of $247.

November 22, 4:38 PM

Longtime activist investor Carl Icahn is still shorting GameStop Corp (NYSE: GME) and has been since early 2021.

April 25, 9:21 PM

Major Wall Street indices closed over 1% lower on Tuesday as a plunge in deposits at First Republic…